Active substance
Vitamin a
- US FDA 31
- Safety 5
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| AQUASOL A | EQ 50,000 UNITS BASE/ML | injectable · injection | CASPER PHARMA LLC | Prescription | 18 May 1949 |
| AFAXIN | EQ 50,000 UNITS BASE | capsule · oral | STERLING WINTHROP | Discontinued | 17 Nov 1972 |
| VITAMIN A | EQ 50,000 UNITS BASE | capsule · oral | IVAX SUB TEVA PHARMS | Discontinued | 19 Dec 1972 |
| VITAMIN A | EQ 50,000 UNITS BASE | capsule · oral | IVAX SUB TEVA PHARMS | Discontinued | 20 Dec 1972 |
| VI-DOM-A | EQ 50,000 UNITS BASE | capsule · oral | BAYER PHARMS | Discontinued | 14 Mar 1973 |
| VITAMIN A | EQ 50,000 UNITS BASE; EQ 25,000 UNITS BASE | capsule · oral | MK LABS | Discontinued | 2 May 1973 |
| VITAMIN A | EQ 50,000 UNITS BASE | capsule · oral | WEST WARD | Discontinued | 4 May 1973 |
| VITAMIN A | 50,000USP UNITS | capsule · oral | IMPAX LABS | Discontinued | 13 Jul 1973 |
| ALPHALIN | EQ 50,000 UNITS BASE | capsule · oral | LILLY | Discontinued | 18 Jul 1973 |
| VITAMIN A | EQ 50,000 UNITS BASE | capsule · oral | IMPAX LABS | Discontinued | 1 Aug 1973 |
| VITAMIN A | EQ 50,000 UNITS BASE | capsule · oral | IMPAX LABS | Discontinued | 2 Aug 1973 |
| VITAMIN A | EQ 50,000 UNITS BASE | capsule · oral | WHARTON LABS | Discontinued | 13 Nov 1973 |
| VITAMIN A PALMITATE | EQ 50,000 UNITS BASE/ML | injectable · injection | BEL MAR | Discontinued | 6 Mar 1974 |
| VITAMIN A PALMITATE | EQ 50,000 UNITS BASE | capsule · oral | BANNER PHARMACAPS | Discontinued | 10 Jun 1974 |
| VITAMIN A | 50,000USP UNITS | capsule · oral | BANNER PHARMACAPS | Discontinued | 3 Jul 1974 |
| VITAMIN A | EQ 50,000 UNITS BASE | capsule · oral | BANNER PHARMACAPS | Discontinued | 19 Jun 1980 |
| VITAMIN A | EQ 50,000 UNITS BASE | capsule · oral | CHASE CHEM | Discontinued | |
| DEL-VI-A | EQ 50,000 UNITS BASE | capsule · oral | DEL RAY LABS | Discontinued | |
| VITAMIN A | EQ 50,000 UNITS BASE | capsule · oral | BRISTOL MYERS SQUIBB | Discontinued | |
| VITAMIN A SOLUBILIZED | EQ 50,000 UNITS BASE | capsule · oral | TEVA | Discontinued | |
| VITAMIN A | EQ 50,000 UNITS BASE | capsule · oral | EVERYLIFE | Discontinued | |
| VITAMIN A | 50,000USP UNITS | capsule · oral | WEST WARD | Discontinued | |
| AQUASOL A | 50,000USP UNITS; 25,000USP UNITS | capsule · oral | ASTRAZENECA | Discontinued | |
| VITAMIN A | EQ 50,000 UNITS BASE | capsule · oral | EVERYLIFE | Discontinued | |
| VITAMIN A | 50,000 IU | capsule · oral | EVERYLIFE | Discontinued |
6 more — full table
Safety signals and safety-related labeling changes
- US FDA 6 Nov 2024 INFUVITE ADULT — safety-related labeling change
Labeling sections changed: Use in Specific Populations - US FDA 6 Nov 2024 INFUVITE PEDIATRIC — safety-related labeling change
Labeling sections changed: Use in Specific Populations - US FDA 16 Dec 2020 M.V.I. ADULT — safety-related labeling change
Labeling sections changed: Contraindications; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 9 Nov 2017 M.V.I. ADULT (PHARMACY BULK PACKAGE) — safety-related labeling change
Labeling sections changed: Contraindications; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 9 Nov 2017 M.V.I.-12 — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Combinations containing Vitamin a
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.